These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 11701703

  • 1. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM, Atkinson AB, Ennis C, Hadden DR, McCance DR, Sheridan B, Bell PM.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [Abstract] [Full Text] [Related]

  • 4. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
    Kousta E, Chrisoulidou A, Lawrence NJ, Anyaoku V, Al-Shoumer KA, Johnston DG.
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):17-24. PubMed ID: 10651749
    [Abstract] [Full Text] [Related]

  • 5. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM, Coyte D, Camacho-Hübner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [Abstract] [Full Text] [Related]

  • 6. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M, Hew FL, Oakley M, Rantzau C, Alford F.
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 8. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
    Beshyah SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W, Sharp P, Johnston DG.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
    [Abstract] [Full Text] [Related]

  • 9. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.
    Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO.
    J Clin Endocrinol Metab; 2002 May; 87(5):2121-7. PubMed ID: 11994351
    [Abstract] [Full Text] [Related]

  • 10. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
    Nørrelund H, Vahl N, Juul A, Møller N, Alberti KG, Skakkebaek NE, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
    [Abstract] [Full Text] [Related]

  • 11. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R, Johnston DG.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG.
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA, Ali K, Anyaoku V, Niththyananthan R, Johnston DG.
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [Abstract] [Full Text] [Related]

  • 15. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 16. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [Abstract] [Full Text] [Related]

  • 17. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC, Dunger DB.
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [Abstract] [Full Text] [Related]

  • 18. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B, Link K, Ahrén B, Nilsson AS, Erfurth EM.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [Abstract] [Full Text] [Related]

  • 19. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hübner C, Savage MO, Monson JP.
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [Abstract] [Full Text] [Related]

  • 20. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
    Yuen K, Ong K, Husbands S, Chatelain P, Fryklund L, Gluckman P, Ranke M, Cook D, Rosenfeld R, Wass J, Dunger D.
    J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.